C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2001
12/13/2001	US20010051630 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses
12/13/2001	US20010051626 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
12/13/2001	US20010051623 8-(Piperidin-4-yl- or piperazin-1-yl)-2-substituted-tetralin derivatives; selective effect at a subgroup of 5-hydroxytryptamine receptors, h5-HT1B receptors (previously 5-HT1D beta); antagonists; mood disorders, antianxiolytic
12/13/2001	US20010049848 Direct dyes; hair dyes
12/13/2001	DE10027611A1 New 2,4-disubstituted 5-sulfonyl-benzamides or analogs having LDL receptor inducing activity, useful for treating or preventing hyperlipidemia or arteriosclerosis
12/13/2001	CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP1161416A1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0912499B1 Pesticides
12/12/2001	EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/12/2001	EP0765865B1 2-acylaminopropanol compound and medicinal composition
12/12/2001	CN1076020C Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions
12/12/2001	CN1076018C N-alkyl ammonium acetonitrile bleach activators
12/12/2001	CN1076016C O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
12/11/2001	US6329409 Amine derivatives and skin preparations for external use containing the same
12/11/2001	US6329399 Antifungal amine derivatives and processing for producing the same
12/11/2001	US6329395 Urea derivatives for treating an eating disorder or diabetes comprising administering an effective amount of a compound of claim 1 to a mammal
12/11/2001	US6329377 Enzyme inhibitors for nervous system disorders
12/11/2001	CA2053709C Piperazine derivatives
12/06/2001	WO2001092241A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
12/06/2001	WO2001092220A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
12/06/2001	WO2001092212A1 Excitatory amino acid receptor modulators
12/06/2001	WO2001051474A3 Polypharmacophoric agents
12/06/2001	US20010049440 Process for preparing Cis-2,6-dimethylpiperazine
12/06/2001	US20010049374 Amidino derivatives of quinoline and naphthalene
12/06/2001	US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
12/05/2001	EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s
12/05/2001	EP1159264A2 INHIBITORS OF FACTOR Xa
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1158985A1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
12/05/2001	EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
12/05/2001	CN1325391A Drug dependence remedies
12/04/2001	USH2007 Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	US6326369 Bicyclic quinone compounds, their production and use
12/04/2001	CA2171882C Inhibitors of .beta.-amyloid protein production
11/2001
11/29/2001	WO2001090717A2 Linker arms for nanocrystals and compounds thereof
11/29/2001	WO2001090716A2 Linker arms for nanocrystals and compounds thereof
11/29/2001	WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/29/2001	WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	WO2001089493A2 Compositions containing a benzamide disulfide derivative for treating allergic diseases
11/29/2001	US20010047097 Base-catalyzed with high selectivity in the 2-position of the aryl olefin independently of the position of the double bond in the olefin compound; catalyst selectivity
11/29/2001	US20010047001 Protecting skeletal muscles against trauma damage and subsequent to disease; treating shock and cardiovascular diseases; preserving donor tissue and organs used in transplants
11/29/2001	DE10025663A1 New arylacetic acid N-phenylamide or arylcarboxylic acid N-benzylamide derivatives, used as antithrombotic agents in treatment of e.g. deep leg vein thrombosis, are Factor Xa and thrombin inhibitors
11/29/2001	CA2410593A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	CA2407767A1 Compositions containing a benzamide disulfide derivative for treating allergic diseases
11/28/2001	EP1157985A1 Para- substituted phenylene derivatives and their use as integrin antagonists
11/28/2001	EP1157983A1 Process for the preparation of arylethylamines via the amination of arylolefins
11/28/2001	EP1157617A2 Use of alpha-keto enamine derivatives as ingredients
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157017A1 N-substituted imide derivatives with serotonergic activity
11/28/2001	EP1157016A1 A process for the preparation of 2- 2- 4-(diphenylmethyl)-1-piperazinyl]ethoxy acetic acid compounds or salts thereof
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
11/28/2001	EP0673368B1 Novel nicotinic acid esters
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/27/2001	US6323367 Reacting tertiary or secondary amine with hydrogen peroxide as an oxidant in presence of a recyclable heterogeneous layered double hydroxide exchanged with transition metal oxides as a catalyst in an organic solven, stirring, filtration
11/27/2001	US6323345 Process for Cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine
11/27/2001	US6323243 Aromatic ether with amine or amide groups
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323207 Treatment or reduction of tissue damage due to ischaemia which comprises administering to a host suffering from ischaemia
11/27/2001	US6323202 Benzamide substitutes with ketone compounds as enzyme inhibitors
11/23/2001	CA2348301A1 Use of alpha-keto enamine derivatives as ingredients
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087865A1 A new process for the synthesis of morpholinylbenzenes
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087299A1 Aralkyl ester soft drugs
11/22/2001	WO2001087293A1 -secretase inhibitors
11/22/2001	WO2001023369A3 Process for preparing benzoic acids
11/22/2001	WO2000035879A8 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
11/22/2001	US20010044541 Useful in protecting skeletal muscles against damage resulting from trauma or to protect against limping, treating shock conditions, preserve donor tissue and organs used in transplants, and in treating cardiovascular diseases
11/22/2001	US20010044434 Treating timidity and enhancing libido in postmenopausal women, or treating male sexual dysfunction by administering to a patient in need thereof an effective amount of an estrogen agonist/antagonist
11/22/2001	US20010044420 Treatment of mammalian cancer
11/22/2001	DE10025114A1 Verfahren zur Herstellung von Arylethylaminen durch Aminierung von Arylolefinen A process for preparing arylethylamines by amination of arylolefins
11/22/2001	DE10021790A1 Production of omega-aminoalkanesulphonic acids comprises reaction of a secondary amine with a dihaloalkane and an alkali sulfite in aqueous solution
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001	CA2409116A1 Substituted thioacetamides
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2407473A1 A new process for the synthesis of morpholinylbenzenes
11/22/2001	CA2407099A1 Aralkyl ester soft drugs
11/22/2001	CA2407088A1 Beta-secretase inhibitors
11/21/2001	EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001	EP1154983A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists

1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 341